EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a cystic fibrosis screening system incorporating a miniature sweat stimulator and disposable chloride sensor


Clinical Chemistry 32(5): 850-853
Evaluation of a cystic fibrosis screening system incorporating a miniature sweat stimulator and disposable chloride sensor
A new sweat test (CF Indicator; Medtronic, Inc.) for cystic fibrosis (CF) features a compact, portable configuration of electrodes that dispense pilocarpine for iontophoresis. A disposable chloride sensor patch absorbs a specified volume of sweat, in which the chloride concentration is immediately determined as less than 40, 40-60, or greater than 60 mmol/L. We assessed the performance of the system in a five-center study, in relation to the clinical diagnosis and to the Gibson-Cooke sweat test (GCST) as a control test. With sweat chloride concentrations of less than or equal to 40 mmol/L defined as normal and greater than 40 mmol/L as indicating persons at risk for CF, the new system showed 91% specificity and 100% sensitivity for CF, as compared with 92.8% and 100%, respectively, for the GCST. When we used sweat chloride concentrations of less than or equal to 60 mmol/L as probably normal and greater than 60 mmol/L as probably indicative of CF, the new system showed a 99.1% specificity and 98.6% sensitivity, vs 97.8% specificity and 97.9% sensitivity for the GCST test. In both procedures, occasionally insufficient sweat was collected, and this appeared related to the age of the subject. We conclude that the new sweat test system is potentially useful in physicians' offices, in clinics, and similar settings.

(PDF 0-2 workdays service: $29.90)

Accession: 005395046

PMID: 3698274



Related references

Screening for cystic fibrosis with chloride electrode. An investigation of sweat chloride with chloride electrode orion 417 in normal persons and in patients with cystic fibrosis. Danish Medical Bulletin 21(6): 251-255, 1974

Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening. European Journal of Pediatrics 174(8): 1025-1034, 2016

Diagnosis of cystic fibrosis with chloride meter (Sherwood M926S chloride analyzer®) and sweat test analysis system (CFΔ collection system®) compared to the Gibson Cooke method. Turkish Journal of Pediatrics 58(1): 27-33, 2016

Quantitative iontophoretic sweat chloride screening and DNA analysis for the diagnosis of cystic fibrosis. Clinical Chemistry 42(6 PART 2): S281, 1996

Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?. Diagnostic Pathology 11(1): 103-103, 2016

Sweat testing for cystic fibrosis. Diagnostic screening with a combination chloride ion-selective electrode. Archives of Disease in Childhood 53(6): 483-486, 1978

Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?. Paediatric Respiratory Reviews 20: 48-50, 2016

Quantification of chloride in sweat with the Cystic Fibrosis Indicator System. Clinical Chemistry 36(1): 96-98, 1990

The use of sweat chloride test for screening cystic fibrosis among malnourished children suffering from frequent respiratory infections. Saudi Medical Journal 30(12): 1526-1531, 2010

Electrochemical detection of chloride levels in sweat using silver nanoparticles: a basis for the preliminary screening for cystic fibrosis. Analyst 138(15): 4292-4297, 2014